These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

483 related articles for article (PubMed ID: 29363047)

  • 41. [Genetic aspects of polycystic ovary syndrome].
    Jakubowski L
    Endokrynol Pol; 2005; 56(3):285-93. PubMed ID: 16350721
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Obesity and the polycystic ovary syndrome.
    Martínez-Bermejo E; Luque-Ramírez M; Escobar-Morreale HF
    Minerva Endocrinol; 2007 Sep; 32(3):129-40. PubMed ID: 17912153
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Evidence-based approach to cutaneous hyperandrogenism in women.
    Schmidt TH; Shinkai K
    J Am Acad Dermatol; 2015 Oct; 73(4):672-90. PubMed ID: 26138647
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Polycystic Ovarian Syndrome.
    Shrivastava S; Conigliaro RL
    Med Clin North Am; 2023 Mar; 107(2):227-234. PubMed ID: 36759093
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The evaluation of metabolic parameters and insulin sensitivity for a more robust diagnosis of the polycystic ovary syndrome.
    Amato MC; Galluzzo A; Finocchiaro S; Criscimanna A; Giordano C
    Clin Endocrinol (Oxf); 2008 Jul; 69(1):52-60. PubMed ID: 18034780
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The clinical significance and primary determinants of hirsutism in patients with polycystic ovary syndrome.
    Panidis D; Tziomalos K; Papadakis E; Chatzis P; Kandaraki EA; Tsourdi EA; Vosnakis C; Katsikis I
    Eur J Endocrinol; 2013 Jun; 168(6):871-7. PubMed ID: 23557988
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The polycystic ovary syndrome: a position statement from the European Society of Endocrinology.
    Conway G; Dewailly D; Diamanti-Kandarakis E; Escobar-Morreale HF; Franks S; Gambineri A; Kelestimur F; Macut D; Micic D; Pasquali R; Pfeifer M; Pignatelli D; Pugeat M; Yildiz BO;
    Eur J Endocrinol; 2014 Oct; 171(4):P1-29. PubMed ID: 24849517
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Polycystic ovary syndrome in adolescent girls.
    Baldauff NH; Witchel SF
    Curr Opin Endocrinol Diabetes Obes; 2017 Feb; 24(1):56-66. PubMed ID: 27906711
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Polycystic ovarian syndrome.
    Trikudanathan S
    Med Clin North Am; 2015 Jan; 99(1):221-35. PubMed ID: 25456652
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Diagnostic criteria for polycystic ovary syndrome: pitfalls and controversies.
    Lujan ME; Chizen DR; Pierson RA
    J Obstet Gynaecol Can; 2008 Aug; 30(8):671-679. PubMed ID: 18786289
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Polycystic ovary syndrome: a review for dermatologists: Part I. Diagnosis and manifestations.
    Housman E; Reynolds RV
    J Am Acad Dermatol; 2014 Nov; 71(5):847.e1-847.e10; quiz 857-8. PubMed ID: 25437977
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Hyperandrogenism.
    Yadav V; Sharma Y
    Indian J Pediatr; 2023 Oct; 90(10):1018-1024. PubMed ID: 37402107
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Polycystic Ovary Syndrome.
    Meier RK
    Nurs Clin North Am; 2018 Sep; 53(3):407-420. PubMed ID: 30100006
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Hyperandrogenemia association with acne and hirsutism severity in Croatian women with polycystic ovary syndrome.
    Pavičić Baldani D; Škrgatić L; Bukvić Mokos Z; Trgovčić I
    Acta Dermatovenerol Croat; 2013; 21(2):105-12. PubMed ID: 24001418
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [National consensus on hyperandrogenemia].
    Aganović I; Alac M; Cabrijan T; Grizelj V; Korsić M; Misjak-Vitez M; Reiner Z; Suchanek E; Simunić V; Zjacić-Rotkvić V
    Lijec Vjesn; 1996 Sep; 118(9):189-90. PubMed ID: 9011736
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Polycystic ovary syndrome in adolescence.
    Buggs C; Rosenfield RL
    Endocrinol Metab Clin North Am; 2005 Sep; 34(3):677-705, x. PubMed ID: 16085166
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Effect of long-term treatment with metformin added to hypocaloric diet on body composition, fat distribution, and androgen and insulin levels in abdominally obese women with and without the polycystic ovary syndrome.
    Pasquali R; Gambineri A; Biscotti D; Vicennati V; Gagliardi L; Colitta D; Fiorini S; Cognigni GE; Filicori M; Morselli-Labate AM
    J Clin Endocrinol Metab; 2000 Aug; 85(8):2767-74. PubMed ID: 10946879
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Polycystic ovary syndrome: definition, aetiology, diagnosis and treatment.
    Escobar-Morreale HF
    Nat Rev Endocrinol; 2018 May; 14(5):270-284. PubMed ID: 29569621
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effects of metformin therapy on hyperandrogenism in women with polycystic ovarian syndrome.
    Kazerooni T; Dehghan-Kooshkghazi M
    Gynecol Endocrinol; 2003 Feb; 17(1):51-6. PubMed ID: 12724019
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Endocrine and metabolic characteristics in polycystic ovary syndrome.
    Glintborg D
    Dan Med J; 2016 Apr; 63(4):. PubMed ID: 27034186
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.